Literature DB >> 11816716

The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen.

C Oury1, E Toth-Zsamboki, C Thys, J Tytgat, J Vermylen, M F Hoylaerts.   

Abstract

ATP is a potent agonist of the P2X1 ion channel, mediating a rapid, quickly desensitized influx of Ca2+. In hirudinized PRP, containing apyrase, the two stable selective P2X1 agonists, alpha,beta-methylene ATP, and L-beta,gamma-methylene ATP induced extracellular Ca2+-dependent fast and reversible platelet shape change, leading to desensitization of the P2X1 ion channel. Preincubation with HPLC-purified ADP potently antagonized the subsequent alpha,beta-methylene ATP- and L-beta,gamma-methylene ATP-evoked platelet shape change. Accordingly, upon heterologous expression of P2X1 in Xenopus oocytes. HPLC-purified ADP acted as an antagonist of the ATP-induced current, but was inactive itself. Since ATP and ADP are co-released from dense granules during platelet activation, we investigated whether the P2X1 ion channel is involved in the response of platelets to collagen. We found that platelet shape change and aggregation induced by low concentrations of collagen were strongly inhibited after selective desensitization of P2X1 with its agonists or by pretreating the platelets with a low concentration of ADP (0.5 microM), that antagonizes the P2X1 channel without desensitizing the P2Y1 receptor. Our data suggest that, during collagen-initiated platelet activation, the early secretion of ATP results in the activation of the P2X1 ion channel, which plays a role as a positive regulator of further platelet responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11816716

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.

Authors:  Susanne Horner; Kirsten Menke; Caren Hildebrandt; Matthias U Kassack; Peter Nickel; Heiko Ullmann; Martyn P Mahaut-Smith; Günter Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-09-13       Impact factor: 3.000

2.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Authors:  Roxane Darbousset; Céline Delierneux; Soraya Mezouar; Alexandre Hego; Christelle Lecut; Isabelle Guillaumat; Markus A Riederer; Richard J Evans; Françoise Dignat-George; Laurence Panicot-Dubois; Cécile Oury; Christophe Dubois
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

4.  Molecular defects of the platelet P2 receptors.

Authors:  Marco Cattaneo
Journal:  Purinergic Signal       Date:  2011-01-29       Impact factor: 3.765

Review 5.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

Review 6.  P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.

Authors:  C Y E Fung; Aaron J Marcus; M Johan Broekman; Martyn P Mahaut-Smith
Journal:  Trends Cardiovasc Med       Date:  2009-01       Impact factor: 6.677

7.  ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMP.

Authors:  Jaione Burzaco; Manuel Conde; Luis A Parada; José L Zugaza; Jean-Paul Dehaye; Aida Marino
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  The P2X1 receptor and platelet function.

Authors:  Martyn P Mahaut-Smith; Sarah Jones; Richard J Evans
Journal:  Purinergic Signal       Date:  2011-03-22       Impact factor: 3.765

9.  Heat shock protein 90 inhibitors reduce trafficking of ATP-gated P2X1 receptors and human platelet responsiveness.

Authors:  Ulyana Lalo; Sarah Jones; Jonathan A Roberts; Martyn P Mahaut-Smith; Richard J Evans
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

10.  Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet.

Authors:  C Y E Fung; C Cendana; R W Farndale; M P Mahaut-Smith
Journal:  J Thromb Haemost       Date:  2007-03-14       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.